-
Use Cases
-
Resources
-
Pricing
The history of antibiotics traces the scientific journey from ancient observations of mold's healing properties to the revolutionary discovery of penicillin by Alexander Fleming in 1928, followed by the golden age of antibiotic development, mass production during World War II, and ongoing efforts to combat antibiotic resistance. More Less
1874
% complete
In 1874, physician Sir William Roberts noted that cultures of the mould Penicillium glaucum used in making some types of blue cheese did not display bacterial contamination, an early observation of antibiosis.
Image source: Antibiotic
1877
% complete
Antibiosis was first described in 1877 in bacteria when Louis Pasteur and Robert Koch observed that an airborne bacillus could inhibit the growth of Bacillus anthracis.
1895
% complete
In 1895, Vincenzo Tiberio, an Italian physician, published a paper on the antibacterial power of some extracts of mold, contributing to early scientific study of antimicrobial substances.
Image source: Vincenzo Tiberio
1897
% complete
In 1897, doctoral student Ernest Duchesne submitted a dissertation on antagonism between moulds and microbes, the first known scholarly work to consider the therapeutic capabilities of moulds resulting from their anti-microbial activity.
Image source: Ernest Duchesne
1900
% complete
Before the early 20th century, treatments for infections were based primarily on medicinal folklore, with remedies passed down through tradition rather than scientific understanding of microbial causes of disease.
1907
% complete
After screening hundreds of dyes against various organisms, Paul Ehrlich discovered a medicinally useful drug, the first synthetic antibacterial organoarsenic compound salvarsan. This heralded the era of antibacterial treatment begun with arsenic-derived synthetic antibiotics by Alfred Bertheim and Ehrlich.
Image source: Arsphenamine
1908
% complete
In 1908, Ehrlich received the Nobel Prize in Physiology or Medicine for his contributions to immunology, recognizing his pioneering work that laid foundations for chemotherapy and antibacterial drug development.
Image source: Paul Ehrlich
1910
% complete
In 1910, Ehrlich and Hata announced their discovery, which they called drug '606', at the Congress for Internal Medicine at Wiesbaden, introducing a targeted treatment for syphilis.
Dec 1910
% complete
The Hoechst company began to market the compound toward the end of 1910 under the name Salvarsan, now known as arsphenamine. The drug was used to treat syphilis in the first half of the 20th century.
1911 - 1913
% complete
Hata was nominated for the Nobel Prize in Chemistry in 1911 and for the Nobel Prize in Physiology or Medicine in 1912 and 1913, reflecting recognition of his role in developing Salvarsan.
Image source: Sahachiro Hata
1932 - 1933
% complete
The first sulfonamide and the first systemically active antibacterial drug, Prontosil, was developed by a research team led by Gerhard Domagk at the Bayer Laboratories of the IG Farben conglomerate in Germany, for which Domagk received the 1939 Nobel Prize in Physiology or Medicine.
Image source: Prontosil
1928
% complete
Alexander Fleming (1881–1955) discovered modern-day penicillin in 1928, postulating that the mould must secrete an antibacterial substance, which he named penicillin. Its widespread use proved significantly beneficial during wartime.
Image source: Alexander Fleming
1939
% complete
Since the first pioneering efforts of Howard Florey and Chain in 1939, the importance of antibiotics, including antibacterials, to medicine has led to intense research into producing antibacterials at large scales.
Image source: Howard Florey
1942
% complete
The chemical structure of penicillin was first proposed by Abraham in 1942 and then later confirmed by Dorothy Crowfoot Hodgkin in 1945 using X-ray crystallography.
Image source: Edward Abraham
1942
% complete
Ernst Chain, Howard Florey, and Edward Abraham succeeded in purifying the first penicillin, penicillin G, in 1942, but it did not become widely available outside the Allied military before 1945.
Image source: Penicillin
1945
% complete
For their successful development of penicillin, which Fleming had accidentally discovered but could not develop himself as a therapeutic drug, Chain and Florey shared the 1945 Nobel Prize in Medicine with Fleming.
1935 - 1968
% complete
During the mid-20th century, the number of new antibiotic substances introduced for medical use increased significantly. From 1935 to 1968, 12 new classes were launched, marking the golden age of antibiotic discovery.
1939
% complete
In 1939, coinciding with the start of World War II, Dubos reported the discovery of the first naturally derived antibiotic, tyrothricin, a compound of 20% gramicidin and 80% tyrocidine, from Bacillus brevis.
Image source: Tyrothricin
1942
% complete
The term antibiotic was first used in 1942 by Selman Waksman and his collaborators in journal articles to describe any substance produced by a microorganism that is antagonistic to the growth of other microorganisms in high dilution.
Image source: Selman Waksman
1947
% complete
These drugs were later renamed antibiotics by Selman Waksman, an American microbiologist, in 1947, establishing the modern terminology for this class of medicines.
May 2017
% complete
According to the WHO, fifty one new therapeutic entities - antibiotics (including combinations), are in phase 1–3 clinical trials as of May 2017, offering hope for replenishing the antibiotic pipeline.
1943
% complete
Antibacterial selection for strains having previously acquired antibacterial-resistance genes was demonstrated in 1943 by the Luria–Delbrück experiment, providing key insight into how bacterial resistance arises.
Image source: Luria–Delbrück experiment
1969 - 2003
% complete
However, the number of new classes dropped markedly, with only two new classes introduced between 1969 and 2003, raising concerns about the antibiotic development pipeline.
1970
% complete
The emergence of antibiotic resistance prompted restrictions on antibiotic use in the UK in 1970, following the Swann report of 1969, addressing growing concerns over resistant bacterial strains.
Image source: Ben Swann
1977
% complete
In the United States, the question of emergence of antibiotic-resistant bacterial strains due to use of antibiotics in livestock was raised by the US Food and Drug Administration (FDA) in 1977.
Image source: Antibiotic use in livestock
2002
% complete
In France, an 'Antibiotics are not automatic' government campaign started in 2002 and led to a marked reduction of unnecessary antibiotic prescriptions, especially in children.
Image source: Antimicrobial resistance
2003
% complete
The European Union banned the use of antibiotics as growth-promotional agents since 2003, a major regulatory step against nontherapeutic antibiotic use in food animals.
2007
% complete
Bills aimed at phasing out nontherapeutic use of antibiotics in US food animals were proposed, but have not passed, reflecting ongoing legislative efforts in the United States.
Image source: Antibiotic
Mar 2012
% complete
In March 2012, the United States District Court for the Southern District of New York, ruling in an action brought by the Natural Resources Defense Council and others, ordered the FDA to revoke approvals for the use of antibiotics in livestock, which violated FDA regulations.
Image source: Natural Resources Defense Council
2018
% complete
The WHO report on surveillance of antibiotic consumption published in 2018 analysed 2015 data from 65 countries, providing a comprehensive picture of worldwide antibiotic use patterns.
Image source: World Health Organization
2019
% complete
Global deaths attributable to antimicrobial resistance (AMR) numbered 1.27 million in 2019, underscoring the severe public health threat posed by resistant bacteria.
Or browse the full history timeline directory, with more than 2,000 topics.
This History of Antibiotics timeline was generated with the help of AI, using information found on the internet.
We work hard to keep these timelines accurate, but mistakes do get through. If you spot one, email us at [email protected] and we'll fix it for future visitors.
Generate yours with AI or build it from scratch, for free.
Export your timeline, add your own events, edit or remove AI-generated events, and much more
No credit card required.
Cancel anytime.
Cancel anytime.
You can create an unlimited number of timelines with up to 10 events on each one, customize how they look, export them to PDF, PNG, PowerPoint, CSV, and Excel, and share them with a link. Paid plans raise the event limit and add features like spreadsheet imports and collaborators.
Yes. You can cancel your subscription from your account page at any time, and you will not be charged again. Your subscription stays active for the rest of the period you already paid for.
Yes. We will email you a reminder before the annual renewal, and we will also email you a receipt.
Yes. You can email us within 15 days of any payment, and we will issue you a full refund.
Check out our pricing docs or send us an email anytime: [email protected].